Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 10:03 am Purchase | 2026-06-30 | 13G | BIODEXA PHARMACEUTICALS PLC SP BDRX | Armistice Capital, LLC | 26,166 9.990% | 26,147 (+137615.79%) | Filing History |
| 2026-05-15 11:08 am Purchase | 2026-03-31 | 13G | BIODEXA PHARMACEUTICALS PLC SP BDRX | Armistice Capital, LLC | 19 9.990% | 13 (+216.67%) | Filing History |
| 2026-02-17 9:55 pm Purchase | 2025-12-31 | 13G | BIODEXA PHARMACEUTICALS INC SP BDRX | Armistice Capital, LLC | 6 9.990% | 6 (New Position) | Filing History |
| 2026-01-20 1:49 pm Purchase | 2025-12-31 | 13G | BIODEXA PHARMACEUTICALS INC SP BDRX | SABBY MANAGEMENT LLC | 4 9.900% | 4 (New Position) | Filing History |
| 2025-11-14 4:18 pm Sale | 2025-06-30 | 13G | BIODEXA PHARMACEUTICALS INC SP BDRX | C/M Capital Master Fund, LP | 0 0.000% | -3,505 (Position Closed) | Filing History |
| 2025-05-28 5:59 pm Purchase | 2025-05-20 | 13G | BIODEXA PHARMACEUTICALS INC SP BDRX | C/M Capital Master Fund, LP | 3,505 6.800% | 3,505 (New Position) | Filing History |
| 2025-02-18 4:30 pm Unchanged | 2025-02-10 | 13G | BIODEXA PHARMACEUTICALS INC SP BDRX | C/M Capital Master Fund, LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-11-20 11:56 am Unchanged | 2024-11-14 | 13G | BIODEXA PHARMACEUTICALS INC SP BDRX | Brio Capital Master Fund Ltd. | 0 0.900% | 0 (Unchanged) | Filing History |
| 2024-11-14 5:12 pm Sale | 2024-09-30 | 13G | BIODEXA PHARMACEUTICALS INC SP BDRX | Iroquois Capital Management, LLC | 0 0.670% | -90 (Position Closed) | Filing History |
| 2024-11-12 4:30 pm Purchase | 2024-09-30 | 13G | BIODEXA PHARMACEUTICALS INC SP BDRX | Bigger Capital LLC | 139 11.000% | 120 (+631.58%) | Filing History |
| 2024-11-07 4:51 pm Sale | 2024-09-30 | 13G | BIODEXA PHARMACEUTICALS INC SP BDRX | Cavalry Fund I LP | 0 0.000% | -9 (Position Closed) | Filing History |
| 2024-08-08 4:24 pm Unchanged | 2024-07-19 | 13G | BIODEXA PHARMACEUTICALS INC SP BDRX | Iroquois Capital Management, LLC | 90 9.990% | 0 (Unchanged) | Filing History |
| 2024-07-23 3:09 pm Unchanged | 2024-07-15 | 13G | BIODEXA PHARMACEUTICALS INC SP BDRX | Brio Capital Master Fund Ltd. | 0 9.830% | 0 (Unchanged) | Filing History |
| 2024-02-14 8:47 pm Unchanged | 2023-12-31 | 13G | BIODEXA PHARMACEUTICALS INC SP BDRX | Ionic Ventures, LLC | 0 4.900% | 0 (Unchanged) | Filing History |
| 2024-02-14 2:42 pm Unchanged | 2023-12-31 | 13G | BIODEXA PHARMACEUTICALS INC SP BDRX | Armistice Capital, LLC | 0 0.940% | 0 (Unchanged) | Filing History |
| 2024-02-14 2:14 pm Unchanged | 2023-12-31 | 13G | BIODEXA PHARMACEUTICALS INC SP BDRX | CVI Investments, Inc. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-02-13 4:33 pm Unchanged | 2023-12-31 | 13G | BIODEXA PHARMACEUTICALS INC SP BDRX | Cavalry Fund I LP | 9 9.900% | 0 (Unchanged) | Filing History |
| 2024-02-12 4:30 pm Purchase | 2023-12-21 | 13G | BIODEXA PHARMACEUTICALS INC SP BDRX | Bigger Capital LLC | 19 9.900% | 19 (New Position) | Filing History |
| 2024-01-08 4:01 pm Purchase | 2023-12-21 | 13G | BIODEXA PHARMACEUTICALS INC SP BDRX | Mercer Street Global Opportunity Fund LLC | 9 9.990% | 9 (New Position) | Filing History |
| 2023-12-28 4:30 pm Purchase | 2023-12-21 | 13G | BIODEXA PHARMACEUTICALS INC SP BDRX | Cavalry Fund I LP | 9 9.900% | 9 (New Position) | Filing History |